Balyasny Asset Management’s Mersana Therapeutics MRSN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-21,433	Closed	-$1.01M	–	3105
2024 Q3	$1.01M	Buy	+21,433	New	+$946K	﹤0.01%	1963
2024 Q2	–	Sell	-146,240	Closed	-$16.4M	–	2946
2024 Q1	$16.4M	Sell	146,240 -241,686	-62%	-$24M	0.04%	720
2023 Q4	$22.5M	Buy	387,926 +186,290	+92%	+$7.49M	0.06%	554
2023 Q3	$6.4M	Buy	201,636 +8,055	+4%	+$383K	0.02%	1009
2023 Q2	$15.9M	Buy	+193,581	New	+$28.3M	0.04%	610
2023 Q1	–	Sell	-264	Closed	-$38.7K	–	2991
2022 Q4	$38.7K	Sell	264 -2,277	-90%	-$385K	﹤0.01%	2383
2022 Q3	$430K	Buy	2,541 +331	+15%	+$53.8K	﹤0.01%	2079
2022 Q2	$255K	Buy	2,210 +1,069	+94%	+$101K	﹤0.01%	2145
2022 Q1	$114K	Buy	1,141 +556	+95%	+$64.9K	﹤0.01%	2125
2021 Q4	$91K	Buy	+585	New	+$114K	﹤0.01%	1974
2021 Q2	–	Sell	-785	Closed	-$318K	–	2261
2021 Q1	$318K	Buy	+785	New	+$381K	﹤0.01%	1489
2020 Q4	–	Sell	-6,078	Closed	-$2.83M	–	1607
2020 Q3	$2.83M	Buy	+6,078	New	+$3.07M	0.03%	749
2018 Q4	–	Sell	-1,444	Closed	-$361K	–	1638
2018 Q3	$361K	Sell	1,444 -1,860	-56%	-$623K	﹤0.01%	1458
2018 Q2	$1.48M	Buy	+3,304	New	+$1.45M	0.01%	1031

Other funds holding MRSN